Net income · 2013–2025
Regenxbio net income
−$194M+$33.2M · FY2025
Regenxbio (RGNX) reported −$194M in net income for fiscal 2025, +$33.2M from the year before.
| Fiscal year | Net income | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$194M | +$33.2M | Open → |
| FY20242024-12-31 | −$227M | +$36.4M | Open → |
| FY20232023-12-31 | −$263M | +$16.8M | Open → |
| FY20222022-12-31 | −$280M | −$408M | Open → |
| FY20212021-12-31 | $128M | +$239M | Open → |
| FY20202020-12-31 | −$111M | −$16.5M | Open → |
| FY20192019-12-31 | −$94.7M | −$195M | Open → |
| FY20182018-12-31 | $99.9M | +$173M | Open → |
| FY20172017-12-31 | −$73.2M | −$10.2M | Open → |
| FY20162016-12-31 | −$63.0M | −$40.2M | Open → |
| FY20152015-12-31 | −$22.8M | −$18.8M | Open → |
| FY20142014-12-31 | −$4.0M | +$1.4M | Open → |
| FY20132013-12-31 | −$5.4M | — | Open → |
Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Net income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regenxbio net income |url=https://companiesranked.com/en/company/regenxbio/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regenxbio net income. CompaniesRanked. https://companiesranked.com/en/company/regenxbio/net-incomeBibTeX
@misc{companiesranked-en-company-regenxbio-net-income-2026,
author = {{CompaniesRanked}},
title = {{Regenxbio net income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regenxbio/net-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.